Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Low-dose oral minoxidil is effective and well-tolerated for treating hair loss.

Bicalutamide may help treat female pattern hair loss.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Stuff from umbilical cord stem cells helps skin heal and look younger.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

GRHL3 is important for controlling gene activity in skin cells during different stages of their development.

Minoxidil and finasteride are effective for male hair loss; minoxidil also helps female hair loss, with some treatments needing more research.

Some tuberculosis drugs may cause hair loss, but hair might regrow after treatment or changing the drugs.

Some patients' hair grew back black and white after chemotherapy.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Unani medicine helped regrow eyebrow hair in 45 days.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Hair transplantation successfully treated a woman's hair loss caused by a tight ponytail.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

There is an urgent need for better treatments for hair loss caused by chemotherapy.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.